* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download AIDS
Viral phylodynamics wikipedia , lookup
Infection control wikipedia , lookup
Vectors in gene therapy wikipedia , lookup
Transmission (medicine) wikipedia , lookup
Herpes simplex research wikipedia , lookup
Henipavirus wikipedia , lookup
Epidemiology of HIV/AIDS wikipedia , lookup
Canine parvovirus wikipedia , lookup
Diseases of poverty wikipedia , lookup
Lectures for biomedical students Viruses of Herpesviridae 疱疹病毒 Dr. Jing Qian Dept. of Medical Microbiology and Parasitology Medical school, Zhejiang university Email: [email protected] 2014.6.3 Herpesvirus Introduction Herpesvirus Greek word herpein ----to creep Herpesvirus Sarcoma Variable Herpesvirus Sarcoma Human Herpesviruses Latent infection The Virus persists in an occult, or cryptic, from most of the time. There will be intermittent flare-ups of clinical disease, Infectious virus can be recovered during flare-ups. Latent virus infections typically persist for the entire life of the host. Sarcoma Variable Human Herpesviruses (HHV) H Sarcoma Variable Common features • Herpesviruses have large, enveloped icosadeltahedral capsids containing double-stranded DNA genomes. • Herpesviruses encode many proteins that manipulate操纵 the host cell and immune response. • Herpesviruses encode enzymes (DNA polymerase) that promote viral DNA replication and that are good targets for antiviral drugs. • DNA replication and capsid assembly occurs in the nucleus. • Virus is released by exocytosis, cell lysis, and through cell-cell bridges. • Herpesviruses can cause lytic, persistent, latent, and, for Epstein-Barr virus, immortalizing infections. • Herpesviruses are ubiquitous. • Cell-mediated immunity is required for control. Viral genes essential for viral replication in culture Subfamily Herpesvirus Herpes simplex Virus (HSV) • HSV-1 (HHV-1) • HSV-2 (HHV-2) Subfamily infectant reservoir patients and carriers transmitted ways •HSV-1: contact •HSV-2: sexually vertical transmission Pathogenesis • primary and recurrent infections – cytolytic infection • latent infection – latently infected ganglia in a non-replicating state – trigeminal ganglia三叉神经 节(HSV-1); sacral ganglia骶 神经节(HSV-2) Triggers of HSV Recurrences •UV-B radiation (skiing, tanning) •Fever (hence the name "fever blister") •Emotional stress (e.g. final examinations, big date) Primary herpetic gingivostomatitis 原发性疱疹性龈口炎 •Physical stress (irritation) •Menstruation •Foods: Spicy, acidic, allergies •Immunosuppression •Transient (stress related) •Chemotherapy, radiotherapy •Human immunodeficiency virus Cold sore of recurrent herpes labialis 复发性唇泡疹引起的感冒疮 Clinical syndromes • Oropharyngeal disease/ keratoconjunctivitis – HSV-1 (usually) – 6m - 2y • genital herpes – HSV-2 (usually) • herpes encephalitis – HSV-1 (90%) • neonatal herpes – HSV-2 (75%) A baby girl is shown in Slide 22. I took this picture postmortem; the baby was 28 weeks gestation and died of disseminated herpes, neonatal herpes simplex encephalitis. You can see crusted lesions all over the baby's face. http://www.medscape.org/viewarticle/528947_5 Diagnosis multinucleate cell with dark staining inclusions Diagnosis Plaque Assay Diagnosis Diagnosis Treatment • acyclovir • Patients with genital herpes should avoid intercourse when they have the prodromal itching symptoms or an active lesion. Herpesvirus Varicella-Zoster Virus (HHV-3) Subfamily Mechanism of spread of varicella-zoster virus (VZV) within the body means of spreading: respiratory tract and close contact primary target cells mucoepithelial cells place of latency neuron Pathogenesis and clinical syndromes chicken-pox (Varicella) Each spot starts as a 2-4 mm diameter red papule which develops an irregular outline (rose petal) as a small vesicle appears on the surface. This 'dew drop on a rose petal' appearance is very characteristic of chickenpox. Pathogenesis and clinical syndromes ganglia Pathogenesis and clinical syndromes Shingles Pathogenesis and clinical syndromes The virus may then be reactivated under stress or with immune suppression. Congenital Varicella syndrome • caused by infection in utero during the first trimester • leads to scarring of the skin of the limbs, damage to the lens, retina and brain and microphthalmia • or at birth from infected mother • severe skin infection Treatment • acyclovir Vaccine • live attenuated vaccine virus Herpesvirus Cytomegalovirus (HHV5) Subfamily Sources of Cytomegalovirus Infection Age Group Source Neonate Transplacental transmission, intrauterine infections, cervical secretions Baby or child Body secretions: breast milk, saliva, tears, urine Adult Sexual transmission (semen), blood transfusion, organ graft Outcomes of cytomegalovirus (CMV) infections The outcome depends very heavily on the immune status of the patient LABORATORY DIAGNOSIS Histology H&E stain of lung section showing nuclear inclusions with the appearance of an "owl's eye". The inclusion is surrounded by a clear halo that extends to the nuclear membrane. CMV infection can occur without the typical cytomegalic cells. Immune and DNA Probe Techniques Culture Serology Treatment Ganciclovir Foscarnet Acyclovir is not effective Herpesvirus Epstein- Barr Virus (HHV4) Subfamily potential outcomes of EBV infection •replicate in B cells or epithelial cells permissive for EBV replication. •cause latent infection of B cells in the presence of competent T cells. •stimulate and immortalize B cells. Diseases related to EBV infection •Burkitt's lymphoma (Africa) large multinucleated cells Diseases related to EBV infection •Burkitt's lymphoma (Africa) •nasopharyngeal carcinoma (Guangdong, China; areas in southeast Asia) Diseases related to EBV infection •Burkitt's lymphoma (Africa) •nasopharyngeal carcinoma (Guangdong, China; areas in southeast Asia) • infectious mononucleosis (Europe, North America) A conjunctival hemorrhage of the right eye of this patient with infectious mononucleosis. Atypical T-cell (Downey cell) characteristic of infectious mononucleosis. The cells have a more basophilic and vacuolated cytoplasm than normal lymphocytes, and the nucleus may be oval, kidney shaped, or lobulated. The cell margin may seem to be indented by neighboring red blood cells. Treatment and prevention • no drugs available to treat Epstein-Barr virus. • A vaccine is being developed. FDA-Approved Antiviral Treatments for Herpesvirus Infections Herpes Simplex 1 and 2 •Acyclovir •Penciclovir •Valacyclovir •Famciclovir •Adenosine arabinoside •Iododeoxyuridine •Trifluridine Epstein-Barr Virus •None Varicella-Zoster Virus •Acyclovir •Famciclovir •Valacyclovir •Varicella-zoster immune globulin •Zoster immune plasma •Live vaccine Cytomegalovirus •Ganciclovir* •Valganciclovir* •Foscarnet* •Cidofovir* Retroviridae RETROVIRIDAE IMPORTANT ASPECTS 1. Contain a helical nucleoprotein complex inside an icosahedral capsid which is enveloped 2. Genomic RNA undergoes reverse transcription 3. Genome (as DNA) integrated into host cellular DNA 4. Some members carry oncogenes 5. HIV-1, the cause of AIDS HIV Human Immunodeficiency Virus 1+2 AIDS Acquired ImmunoDefiency Syndromes Global situation 2006REPORT ON THE GLOBAL AIDS EPIDEMIC (UNAIDS) UNAIDS: joint united nations programme on HIV/AIDS UNAIDS strategy goals by 2015: •Sexual transmission of HIV reduced by half, including among young people, men who have sex with men and transmission in the context of sex work •Vertical transmission of HIV eliminated, and AIDS-related maternal mortality reduced by half •All new HIV infections prevented among people who use drugs •Universal access to antiretroviral therapy for people living with HIV who are eligible for treatment •TB deaths among people living with HIV reduced by half •People living with HIV and households affected by HIV are addressed in all national social protection strategies and have access to essential care and support •Countries with punitive laws and practices around HIV transmission, sex work, drug use or homosexuality that block effective responses reduced by half •HIV-related restrictions on entry, stay and residence eliminated in half of the countries that have such restrictions •HIV-specific needs of women and girls are addressed in at least half of all national HIV responses •Zero tolerance for gender-based violence “Zero new HIV infections. Zero discrimination. Zero AIDS-related deaths.” HIV AIDS Virology of HIV HIV structure • nucleocapsid – +ssRNA 2copies – reverse transcriptase (RTase) – P24 核心蛋白 • envelope – P17 内膜蛋白 – lipid bilayer membrame – gp120 -- gp41 HIV genome • long terminal repeat, LTR (5’, 3’- end) • 3 structure genes and 6 regulator genes – gag → P55 → P24, P17, P15( P7,P9) – pol → RTase, p32 and protease p10 – env → glycoprotein (gp120 and gp41) – 6 regulator genes • tat, rev and nef are most important HIV genome HIV: 15 proteins (9 genes) and an RNA ~10 kb role of accessory proteins, multiple functions to counter intrinsic, innate and acquired immunity Pox viruses: >100 ORFs (e.g. Smallpox) ~200 kb The structure and genetic map of HIV The HIV replication cycle Electron micrograph showing HIV budding from the cell surface before release. (Courtesy of D Hockley.) The attachment of HIV : Receptor and coreceptor Macrophage lineage Macrophage Dendritic cells Microglial celss M-tropic The attachment of HIV : Receptor and co-receptor T cells Naiive T cells T helper cells T-tropic HIV AIDS Pathogenesis and immunity Disease Mechanisms of HIV • Human immunodeficiency virus primarily infects CD4 T cells and cells of the macrophage lineage (e.g., monocytes, macrophages, alveolar macrophages of the lung, dendritic cells of the skin, and microglial cells of the brain). • Virus causes lytic infection of CD4 T cells and persistent low-level productive infection of macrophage lineage cells. • Virus causes syncytia formation, with cells expressing large amounts of CD4 antigen (T cells) with subsequent lysis of the cells. • Virus alters T-cell and macrophage cell function. CD4+ T cell↓ Means of HIV Escape from the Immune System Time course and stages of human immunodeficiency virus (HIV) disease. HIV AIDS Transmission Routes of HIV transmission •sexual male homosexual heterosexual •parenteral iv drug users blood and blood products •perinatal Routes of HIV transmission ROUTES NOT INVOLVED IN TRANSMISSION: CLOSE PERSONAL CONTACT Household members; Health care workers not exposed to blood Routes of HIV transmission HIV AIDS Clinical syndromes Time course and stages of human immunodeficiency virus (HIV) disease. Clinical findings •HIV-Positive without Symptoms •Early Stages of HIV: Signs and Symptoms •Chronic Phase or Latency: Signs and Symptoms •AIDS: Signs and Symptoms Early Stages of HIV: Signs and Symptoms •Fever •Chills •Rash •Night sweats •Muscle aches •Sore throat •Fatigue •Swollen lymph nodes •Ulcers in the mouth Chronic Phase or Latency: Signs and Symptoms no symptoms last up to 10 years—sometimes longer AIDS: Signs and Symptoms •rapid weight loss •dry cough •recurring fever or profuse night sweats •profound and unexplained fatigue •swollen lymph glands in the armpits, groin, or neck •diarrhea lasting more than a week •white spots or unusual blemishes on the tongue, in the mouth, or in the throat •pneumonia •red, brown, pink, or purplish blotches on or under the skin or inside the mouth, nose, or eyelids •memory loss, depression, and other neurological disorders AIDS: Opportunistic Infections Brain Eyes Cryptoccoccal Menigitis Cytomegalovirus (CMV) HIV-related Encephalopathy Lymphatic System Progressive Multifocal Leukoencephalo pathy (PML) Non-Hodgkin's lymphoma Toxoplasmosis Mouth and Throat Candidiasis Skin Lung Herpes Simplex Coccidiomycosis Kaposi's Sarcoma Histoplasmosis Shingles GI Tract Cryptosporidiosis Cytomegalovirus Mycobacterium Avium Complex Pneumocystis Carinii Recurrent Pneumonia Tuberculosis (TB) The Chronic Phase of HIV-1 1400 Plasma viral titer by PCR or bDNA assay Plasma viral titer by culture or p24 antigen Number of CD4 + cells 106 1200 1000 104 800 103 600 102 400 101 200 1 2 9 CD4+ Count Plasma Viremia 105 10 Time (Years) PCR=polymerase chain reaction; bDNA=branched DNA. Adapted with permission from Saag. In: DeVita et al, eds. AIDS: Etiology, Treatment and Prevention. 4th ed. Lippincott-Raven Publishers; 1997:203-213. The Late Phase of HIV-1 1400 Plasma viral titer by PCR or bDNA assay Plasma viral titer by culture or p24 antigen Number of CD4 + cells 106 1200 1000 104 800 103 600 102 400 101 200 1 2 9 CD4+ Count Plasma Viremia 105 10 Time (Years) PCR=polymerase chain reaction; bDNA=branched DNA. Adapted with permission from Saag. In: DeVita et al, eds. AIDS: Etiology, Treatment and Prevention. 4th ed. Lippincott-Raven Publishers; 1997:203-213. The Variable Course of HIV-1 Infection Typical Progressor AIDS Viral Replication months B months years Nonprogressor years Clinical Latency CD4 Level C Viral Replication Primary HIV Infection AIDS CD4 Level CD4 Level A Primary HIV Infection Viral Replication Primary HIV Infection Clinical Latency Rapid Progressor ? months years Reprinted with permission from Haynes. In: DeVita et al, eds. AIDS: Etiology, Treatment and Prevention. 4th ed. Lippincott-Raven Publishers; 1997:89-99. HIV AIDS HIV Diagnosis Reasons for HIV infection test •To identify those with the infection •To identify carriers who may transmit infection to others specifically: blood or organ donors pregnant women sex partners •To follow the course of disease and confirm the diagnosis of AIDS HIV-diagnosis goes to two steps STEP 1 STEP 2 Case definition of a HIV-positive test result ? Detection of at least one env gene product plus another non-env gene product Confirmed HIV infection Kinetic of viral makers during primary HIV infection Elsevier 2004, Infectious Disease 2e Immunoblot reactivity in a HIV seroconverter equivocal HIV positive Elsevier 2004, Infectious Disease 2e HIV AIDS Treatment, prevention and control Possible sites of intervention in the inhibition of HIV replication Therapeutic intervention Reverse transcriptase inhibitors (RTI) Protease inhibitors Highly active antiretroviral therapy=HAART • since 1983: HAART is a combination therapy of at least 3 antiviral drugs • efficient>80% of those who receive a therapy • reduction of viral replication < 100 copies/mL • reduction in the number of AIDS-affected persons and AIDS-affected persons and AIDS-deaths in USA and Western Europe Elsevier 2004, Infectious Disease 2e Highly active antiretroviral therapy=HAART • since 1983: HAART is a combination therapy of at least 3 antiviral drugs • efficient>80% of those who receive a therapy • reduction of viral replication < 100 copies/mL • reduction in the number of AIDS-affected persons and AIDS-affected persons and AIDS-deaths in USA and Western Europe Remember: AIDS-therapy does not cure!!! Human T-leukemia Virus and Other Oncogenic Retroviruses Groups of Retroviruses • Oncovirinae important Tumor viruses and similar • Lentiviruses important Long latent period Progressive chronic disease HIV •… Retroviruses known to cause human cancer • Human T cell lymphotropic virus -1 (HTLV-1) Adult T cell leukemia, Sezary T-cell leukemia Africa, Caribbean, Some Japanese Islands • Human T cell lymphotropic virus -2 (HTLV-2) Hairy cell leukemia From BSE to Prion Bovine spongiform encephalopathy (BSE) mad-cow disease Global mad cow cases map Dark green areas are countries with confirmed human cases of vCJD. Light green shows countries which have reported cases of only CAUSE? Discovery of PRION •Stanley B. Prusiner of the University of California, San Francisco •Nobel Prize in Physiology or Medicine in 1997 Pathogenesis: from PrPc to PrPsc PrPc (cellular prion protein) PrPsc (scrapie prion protein) in the normal and diseased tissue only in diseased tissue with alfa-helix with beta- pleated sheet and alfa-helix sensitive to protease K resistant to protease K Heterodimer model of prion propagation Prion replication cycle The following diseases are associated with prion • Man – Kuru disease – Creutzfeldt-Jacob disease (CJD) – Gerstmann-Straussler syndrome (GSS) • Animals – scrapie of sheep and goats – transmissible mink encephalopathy(TMM) – bovine spongiform encephalopathy (BSE, crazy cow) The characters of Prion diseases normal rabies virus the virus • member of the Lyassavirus of the Rhabdoviridae • -ssRNA enveloped virus, helical symmetry Pathogenesis: rabies • the commonest mode of transmission in man – by the bite of a rabid animal – the contamination of scratch wounds by virus- infected saliva. 1. Raccoon is bitten by a rabid animal 2. Virus enters wound via saliva 3. Virus spreads through nerves to spinal cord and brain 4. Incubation period of 3-12 weeks with no symptoms 5. In brain the virus replicates and spreads to other tissues including th 6. The animal dies within a week Pathogenesis: rabies • the commonest mode of transmission in man – by the bite of a rabid animal – the contamination of scratch wounds by virus- infected saliva. Pathogenesis: rabies • incubation/prodromal period (usually of up to two weeks), pain or itching at the site of the wound, fever, headache and gastrointestinal problems. • CNS infection • hydrophobia. This fear of water is the result of the pain associated with drinking. • seizures and hallucinations. • paralysis may lead to respiratory failure. • comatose. • Because of the neurological problems including respiratory paralysis, death ensues Pathogenesis: rabies 1. Raccoon is bitten by a rabid animal 2. Virus enters wound via saliva 3. Virus spreads through nerves to spinal cord and brain 4. Incubation period of 3-12 weeks with no symptoms 5. In brain the virus replicates and spreads to other tissues including the salivary glands. Signs of disease occur 6. The animal dies within a week • laboratory diagnosis – dogs and cats in a rabies endemic area should beheld for 10 days for observation – Histopathology : Negri bodies – Rapid virus antigen detection Negri body in infected neuron Human papillomavirus •circular dsDNA, naked •disease skin: warts Genital warts: HPV 6, 11 cervix carcinoma: HPV 16, 18 The Nobel Prize in Physiology or Medicine 2008 Harald zur Hausen Discovery of human papilloma virus causing cervical cancer